ISRCTN77331907已完成不适用
A randomised, controlled, open label, prospective, single centre study to investigate the use of the ENK device when compared to the standard syringe administration of 2% lignocaine solution when performing diagnostic flexible bronchoscopy
ancashire Teaching Hospitals NHS Trust (UK)0 个研究点目标入组 100 人开始时间: 2010年3月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All adult patients (either sex) attending Royal Preston Hospital for diagnostic flexible bronchoscopy
排除标准
- •Patients undergoing interventional procedures (e.g. tracheobronchial stenting, transbronchial biopsy or intrluminal palliative therapies)
研究者
相似试验
招募中
1 期
An unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunosuppressive medication can be tapered without recurrence of symptomsPsoriatic arthritisMedDRA version: 21.1Level: PTClassification code: 10037162Term: Psoriatic arthropathy Class: 100000004859CTIS2023-508251-39-00niversitaetsklinikum Erlangen AöR370
进行中（未招募）
1 期
An unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunosuppressive medication can be tapered without recurrence of symptomsPsoriatic arthritisEUCTR2020-001899-14-DEniversitätsklinikum Erlangen270
已完成
不适用
CLBS12-P01Patients with critical limb ischemia (CLI) due to arteriosclerosis obliterans (ASO) and patients with CLI due to Buerger's Disease (BD)JPRN-jRCT1080223694EPS Corporation (Global Sponsor: Caladrius Biosciences, Inc.)35
已完成
不适用
A prospective, open label, randomized, controlled trial of tocilizumab versus cyclophosphamide in patients with microscopic polyangiitisMicroscopic polyangiitisJPRN-UMIN000011244Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology40
尚未招募
4 期
Transcendental Meditation for healthcare professionalsCTRI/2024/07/071645SMSIMSR, Sri Sathya Sai University for Human Excellence